Show notes
Matt Kerschner, Director of Regulatory Affairs and Policy at the American Academy of Neurology, continues his discussion on the CMS final rule.
Show references: https://www.aan.com/advocacy/how-will-the-cms-fee-schedule-affect-you
Matt Kerschner, Director of Regulatory Affairs and Policy at the American Academy of Neurology, continues his discussion on the CMS final rule.
Show references: https://www.aan.com/advocacy/how-will-the-cms-fee-schedule-affect-you